Back to results
US 11,261,152 B2Granted
Inhibitors of the N-terminal domain of the androgen receptor
AssigneesThe Regents of the University of California, The United States Government as represented by the Department of Veterans Affairs
InventorsMatthew Rettig, Michael E. Jung, D. Elshan Nakath G. Ralalage, Jiabin An
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.
Claims9
A compound represented by formula VIIb:
- wherein:
- each R8 is independently selected from halo, alkyl, or alkyloxy;
- each R9 is independently selected from halo, alkyl, or alkyloxy;
- t is 0, 1, 2, 3, 4, or 5;
- and
- q is 0, 1, 2, 3, 4, or 5.
3 more elements
Dependencies are inferred from the claim text.